Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/12/2002US20020187955 Method of inducing angiogenesis in nonischemic skeletal muscle
12/12/2002US20020187952 Rolling circle replicon expression vectors
12/12/2002US20020187951 Lentiviral-mediated growth factor gene therapy for neurodegenerative diseases
12/12/2002US20020187950 Keratinocyte derived interferon
12/12/2002US20020187947 Inflammation-related gene
12/12/2002US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002US20020187938 Ghrelin antagonists
12/12/2002US20020187934 Peptide derivatives
12/12/2002US20020187930 Substances and their uses
12/12/2002US20020187925 Vaccines; immunology response
12/12/2002US20020187923 Antidiabetic agent; hyperglycemic agents
12/12/2002US20020187922 Novel molecules of the pyrin domain protein family and uses thereof
12/12/2002US20020187553 Packaging systems for human recombinant adenovirus to be used in gene therapy
12/12/2002US20020187550 Generation of genetically engineered cells; obtain embryonic stem cells, culture, incubate with cytokine, recover differentiated cells
12/12/2002US20020187539 Nucleotide sequences coding polypeptide for use in flavonoid biosynthesis in plants
12/12/2002US20020187535 Enzymatic polypeptide for use in the treatment of emphysema, adult respiratory distress syndrome and psoriasis
12/12/2002US20020187526 Neutrokine-alpha binding proteins and methods based thereon
12/12/2002US20020187524 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation, diabetic and psychological disorders
12/12/2002US20020187523 Extracellular signaling molecules
12/12/2002US20020187522 DNA encoding human Cid1
12/12/2002US20020187512 Crystal structure of human interleukin-22
12/12/2002US20020187507 Polynucleotides related to pancreatic disease
12/12/2002US20020187502 Detecting colon carcinoma in humans; obtain tissue sample, monitor expression of preferential genes, compare to control, evaluate for cancer
12/12/2002US20020187495 Genetic polymorphisms of estrogen receptor alpha associated with favorable HDL cholesterol response to hormone replacement therapy
12/12/2002US20020187494 PAR-3 compounds for therapy and diagnosis and methods for using same
12/12/2002US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002US20020187473 Polyamide nucleic acid derivatives, and agents and processes for preparing them
12/12/2002US20020187472 Nucleotide sequences coding protein for use in the treatment of cancer
12/12/2002US20020187469 Protein for use in the treatment of cancer
12/12/2002US20020187466 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection
12/12/2002US20020187206 Method and apparatus for fractional separation of proteins from plant material
12/12/2002US20020187191 Oxidized collagen formulations for use with non-compatible pharmaceutical agents
12/12/2002US20020187185 Gelatin substitute
12/12/2002US20020187162 Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
12/12/2002US20020187161 H. pylori antigens
12/12/2002US20020187160 Vaccine delivery system
12/12/2002US20020187159 The use of heat shock protein 70 preparations in vaccination against cancer and infectious disease
12/12/2002US20020187157 Administering an amyloidogenic polypeptide or subsequence thereof to induces production of antibodies against the amyloidogenic polypeptide; treatment of Alzheimer's disease
12/12/2002US20020187154 Detoxified mutant A subunit or detoxified mutant holotoxin of pertussis toxin (PT) or Pseudomonas endotoxin A, wherein the antigen is not the detoxified mutant.
12/12/2002US20020187153 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
12/12/2002US20020187151 Administering to the mammalian host a composition comprising a multivalent NKG2D-binding agent to a tumor expressing native NKG2D
12/12/2002US20020187149 Activity-inhibiting amount of a growth factor neutralising agent or agents specific against only fibrotic growth factors together with a pharmaceutically acceptible carrier.
12/12/2002US20020187148 T cell receptor ligands and methods of using same
12/12/2002US20020187147 Antigen specific recombinant MHC class II molecules and methods of use
12/12/2002US20020187146 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens
12/12/2002US20020187138 15368, a novel human GTP-releasing factor family member and uses therefor
12/12/2002US20020187135 Methods for inducing antigen-specific t cell tolerance
12/12/2002US20020187131 Conjugating an antigen to a molecule targeted to an endocytic receptor on the dendritic cell, such as DEC-205. The molecule targeted may be a natural ligand to the receptor or an antibody thereto.
12/12/2002US20020187129 Adeno-associated virus materials and methods
12/12/2002US20020187126 Using modified herpes simplex virus (HSV) having a defect in ICP27 (HSV Delta 27), wherein the cancer cell is resistant to anti-cancer therapy.
12/12/2002US20020187124 Asialocytokines and treatment of liver disease
12/12/2002US20020187122 IL-1 delta DNA and polypeptides
12/12/2002US20020187101 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes
12/12/2002DE10147056A1 New pentapeptides containing 5-membered ring in the peptide chain, useful as apoptosis inducing antitumor agents, for treating neurological and/or inflammatory disorders or in tumor diagnosis
12/12/2002DE10127882A1 Cassette for expressing transgene, useful e.g. in production of pharmaceuticals and fine chemicals, contains promoter from the LOX5 gene of Arabidopsis, provides cotyledon-specific expression
12/12/2002CA2830887A1 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
12/12/2002CA2464511A1 Guanylate-cyclase c ligand, administered via the airways, for the treatment of respiratory airway problems
12/12/2002CA2457959A1 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
12/12/2002CA2452865A1 Conditioned cell culture media and uses thereof
12/12/2002CA2451765A1 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
12/12/2002CA2449890A1 B7-related nucleic acids and polypeptides useful for immunomodulation
12/12/2002CA2449777A1 Animal model for allergy
12/12/2002CA2449715A1 Peptides for chlamydophila pneumoniae vaccine and diagnosis
12/12/2002CA2449686A1 Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002CA2449670A1 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002CA2449663A1 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002CA2449658A1 Use of rank antagonists to treat cancer
12/12/2002CA2449487A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
12/12/2002CA2449482A1 Chds as modifiers of the p53 pathway and methods of use
12/12/2002CA2449426A1 Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002CA2449393A1 Method for apo ciii measurement in apob and non apob containing particles
12/12/2002CA2449320A1 Mixtures of growth hormone drug-oligomer conjugates compromising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002CA2449290A1 Mutants of igf binding proteins and methods of production of antagonists thereof
12/12/2002CA2449281A1 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002CA2449275A1 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002CA2449136A1 Igs as modifiers of the p53 pathway and methods of use
12/12/2002CA2449008A1 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
12/12/2002CA2448881A1 Sugar and lipid metabolism regulators in plants ii
12/12/2002CA2448606A1 Nucleic acid-associated proteins
12/12/2002CA2448444A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002CA2448427A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002CA2448384A1 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002CA2448282A1 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002CA2448256A1 Novel human proteins, polynucleotides encoding them and methods of using the same
12/12/2002CA2448073A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/12/2002CA2448066A1 Chimeric alphavirus replicon particles
12/12/2002CA2448044A1 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof
12/12/2002CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002CA2447931A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins and uses thereof
12/12/2002CA2446610A1 20 human secreted proteins
12/12/2002CA2446211A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/12/2002CA2445748A1 Insecticidal proteins and synergistic combinations thereof
12/12/2002CA2442743A1 Human secreted proteins
12/12/2002CA2438571A1 Novel proteins and nucleic acids encoding same
12/12/2002CA2436408A1 Modified psma ligands and uses related thereto
12/12/2002CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002CA2418088A1 Numb protein expression inhibitors by musashi 1
12/12/2002CA2412570A1 Polypeptide, use thereof and method for producing thereof
12/11/2002EP1264890A2 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays
12/11/2002EP1264889A1 Chicken leukemia inhibitory factor (LIF) and the gene thereof
1 ... 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 ... 2916